X4 Pharmaceuticals Inc (NAS:XFOR)
$ 0.9031 0.003 (0.33%) Market Cap: 151.66 Mil Enterprise Value: 129.07 Mil PE Ratio: 0 PB Ratio: 150.52 GF Score: 37/100

Q3 2019 X4 Pharmaceuticals Inc Earnings Call Transcript

Nov 07, 2019 / 01:00PM GMT
Release Date Price: $13.41 (+3.79%)
Operator

Greetings and welcome to X4 Pharmaceuticals Third Quarter 2019 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Stephanie Carrington, Managing Direction of Investor Relations at Westwicke. You may begin.

Stephanie Carrington
Westwicke - Managing Director of Investor Relations

Thank you, Operator. Good morning, everyone, and welcome to X4 Pharmaceuticals Third Quarter 2019 Financial Results and Business Update Conference Call.

I'm joined today by X4 Pharmaceuticals Chief Executive Office, Dr. Paula Ragan; Chief Medical Officer, Dr. Lynne Kelley; and Chief Financial Officer, Adam Mostafa.

Now turning to today's call, Paula will provide an overview of recent developments, Lynne will discuss clinical development progress, and Adam will recap the financial results for the third quarter. We will then open the call to your questions.

But before we begin, I would like to remind you that X4 will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot